| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
501 |
480 |
$35K |
| T1015 |
Clinic visit/encounter, all-inclusive |
1,231 |
221 |
$35K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
221 |
212 |
$26K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
151 |
144 |
$23K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
238 |
229 |
$16K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
60 |
59 |
$11K |
| 80053 |
Comprehensive metabolic panel |
819 |
751 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
821 |
748 |
$4K |
| 80061 |
Lipid panel |
244 |
244 |
$4K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
73 |
73 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
99 |
95 |
$3K |
| 70450 |
Computed tomography, head or brain; without contrast material |
35 |
34 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
29 |
29 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
194 |
183 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
92 |
88 |
$1K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
96 |
86 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
148 |
135 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
109 |
59 |
$1K |
| 84484 |
|
124 |
102 |
$1K |
| 80050 |
General health panel |
18 |
17 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
65 |
62 |
$911.06 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12 |
12 |
$823.54 |
| 83880 |
|
39 |
36 |
$811.61 |
| 83690 |
|
159 |
152 |
$729.74 |
| 83605 |
|
103 |
92 |
$626.45 |
| 82150 |
|
126 |
122 |
$603.44 |
| 81003 |
|
261 |
251 |
$585.21 |
| 84443 |
Thyroid stimulating hormone (TSH) |
66 |
63 |
$520.16 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
29 |
29 |
$464.07 |
| 36415 |
Collection of venous blood by venipuncture |
632 |
532 |
$458.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
26 |
14 |
$439.23 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
54 |
52 |
$410.53 |
| 85610 |
|
166 |
141 |
$339.89 |
| 71045 |
Radiologic examination, chest; single view |
70 |
64 |
$309.50 |
| 85730 |
|
58 |
55 |
$265.92 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
15 |
$255.20 |
| 81001 |
|
104 |
96 |
$248.54 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
48 |
48 |
$244.33 |
| 83735 |
|
60 |
48 |
$237.27 |
| 87040 |
|
17 |
14 |
$228.54 |
| 81025 |
|
50 |
46 |
$218.26 |
| 73030 |
|
14 |
13 |
$216.96 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
21 |
19 |
$156.54 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
28 |
28 |
$150.00 |
| 84439 |
|
22 |
22 |
$144.48 |
| 73630 |
|
14 |
14 |
$144.23 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
96 |
94 |
$111.90 |
| 85027 |
|
15 |
15 |
$99.52 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14 |
13 |
$11.35 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
21 |
18 |
$0.00 |